These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3567885)

  • 21. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.
    Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP
    Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of L-ascorbic acid and urinary electrolytes in promotion of rat bladder carcinogenesis.
    Fukushima S; Shirai T; Hirose M; Ito N
    Princess Takamatsu Symp; 1985; 16():159-68. PubMed ID: 3025161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
    Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion by L-ascorbic acid of urinary bladder carcinogenesis in rats under conditions of increased urinary K ion concentration and pH.
    Fukushima S; Shibata M; Shirai T; Kurata Y; Tamano S; Imaida K
    Cancer Res; 1987 Sep; 47(18):4821-4. PubMed ID: 3621178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
    Fukushima S; Kurata Y; Hasegawa R; Asamoto M; Shibata MA; Tamano S
    Cancer Res; 1991 May; 51(10):2548-51. PubMed ID: 2021935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats.
    Fukushima S; Shibata MA; Shirai T; Tamano S; Ito N
    Cancer Res; 1986 Apr; 46(4 Pt 1):1623-6. PubMed ID: 3948150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose response of N-butyl-N-(4-hydroxybutyl)nitrosamine on urinary bladder carcinogenesis in mutant ODS rats lacking L-ascorbic acid synthesizing ability.
    Mori S; Murai T; Takeuchi Y; Toyama M; Makino S; Konishi T; Hayashi Y; Kurata Y; Fukushima S
    Cancer Lett; 1990 Feb; 49(2):139-45. PubMed ID: 2306707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
    Fukushima S; Hagiwara A; Ogiso T; Shibata M; Ito N
    Food Chem Toxicol; 1983 Feb; 21(1):59-68. PubMed ID: 6681793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters.
    Tamano S; Asakawa E; Boomyaphiphat P; Masui T; Fukushima S
    Teratog Carcinog Mutagen; 1993; 13(2):89-96. PubMed ID: 8102212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
    Murai T; Mori S; Hosono M; Takashima A; Machino S; Oohara T; Yamashita H; Makino S; Matsuda T; Wanibuchi H; Fukushima S
    Jpn J Cancer Res; 1997 Mar; 88(3):245-53. PubMed ID: 9140108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocarcinogenic activity of N-butyl-N-(4-hydroxybutyl)nitrosamine in rats is not modified by sodium L-ascorbate.
    Hagiwara A; Murai T; Yoshino H; Goshima H; Mori S; Takashima A; Shirai T; Fukushima S
    Teratog Carcinog Mutagen; 1999; 19(1):33-42. PubMed ID: 10321408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S; Fukushima S; Shirai T; Hirose M; Ito N
    Cancer Lett; 1987 Apr; 35(1):39-46. PubMed ID: 3567886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification by sodium L-ascorbate, butylated hydroxytoluene, phenobarbital and pepleomycin of lesion development in a wide-spectrum initiation rat model.
    Thamavit W; Fukushima S; Kurata Y; Asamoto M; Ito N
    Cancer Lett; 1989 May; 45(2):93-101. PubMed ID: 2471582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.